Abstract
Whether the diabetic status differentially affects the relative clinical outcomes with different types of drug-eluting stents (DES) has been debated. From prospective registries, 11,428 of non-diabetics and 5,756 of diabetics were analysed; 5,023 cobalt-chromium everolimus-eluting stent (CoCr-EES
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
